Victory Capital Management
CABA icon

Victory Capital Management’s Cabaletta Bio CABA Stock Holding History

Victory Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-629,087
Closed -$2.97M – 2482
2024
Q3 		$2.97M Sell
629,087
-5,130
-0.8% -$29.7K ﹤0.01% 1384
2024
Q2 		$4.74M Buy
634,217
+262,594
+71% +$3.22M ﹤0.01% 1255
2024
Q1 		$6.34M Sell
371,623
-32,304
-8% -$693K 0.01% 1184
2023
Q4 		$9.17M Buy
403,927
+337,277
+506% +$5.67M 0.01% 1086
2023
Q3 		$1.01M Buy
66,650
+6,980
+12% +$95.4K ﹤0.01% 1647
2023
Q2 		$770K Buy
+59,670
New +$648K ﹤0.01% 1799
2022
Q4 		– Sell
-42,586
Closed -$28K – 2604
2022
Q3 		$28K Sell
42,586
-115
-0.3% -$138 ﹤0.01% 2606
2022
Q2 		$45K Buy
42,701
+42
+0.1% +$59 ﹤0.01% 2557
2022
Q1 		$59K Sell
42,659
-221,565
-84% -$579K ﹤0.01% 2582
2021
Q4 		$1M Buy
264,224
+44,438
+20% +$474K ﹤0.01% 1829
2021
Q3 		$2.67M Buy
219,786
+171,529
+355% +$1.58M ﹤0.01% 1495
2021
Q2 		$415K Sell
48,257
-2,173
-4% -$21.4K ﹤0.01% 2295
2021
Q1 		$560K Sell
50,430
-46
-0.1% -$562 ﹤0.01% 2151
2020
Q4 		$630K Sell
50,476
-836
-2% -$10.8K ﹤0.01% 1960
2020
Q3 		$556K Sell
51,312
-20,201
-28% -$232K ﹤0.01% 1920
2020
Q2 		$797K Sell
71,513
-72,979
-51% -$559K ﹤0.01% 1826
2020
Q1 		$1.05M Buy
144,492
+69,492
+93% +$953K ﹤0.01% 1831
2019
Q4 		$1.05M Buy
+75,000
New +$889K ﹤0.01% 1739

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's CABA Position: Q4 2024 in Review

Victory Capital Management sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 629,087 shares — an estimated $2.97M sold.

Victory Capital Management first reported a position in CABA in Q4 2019 and held it in 18 quarters. The position peaked at $9.17M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • Victory Capital Management reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 629,087 Cabaletta Bio shares in Q4 2024, an estimated $2.97M.
  • Victory Capital Management first reported a position in Cabaletta Bio in Q4 2019 and held it in 18 quarters.
  • Victory Capital Management's Cabaletta Bio position peaked at $9.17M in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.